Why INR is outside the therapeutic range in patients with acuteischemic stroke and atrial fibrillation

Why INR is outside the therapeutic range in patients with acuteischemic stroke and atrial fibrillation

Introduction: Warfarin is still the primary drug used to prevent vascular events in patientswith atrial fibrillation (AF), especially in low-income countries. Therapeutic failure and non-adherenceare common causes of recurrent embolic events. The aim of this study was toinvestigate possible reasons...

Full description

Bibliographic Details
Main Authors: Elyar Sadeghi Hokmabadi, Sheida Shaafi, Yalda Sadeghpour, Reza Deljavan, Javad Jalili, Morteza Ghojazadeh, Elyar Alizade Najmi, Saeid Charsouei, Mehdi Farhoudi
Format: Article
Language:English
Published: Tabriz University of Medical Sciences Press 2022-04-01
Series:Journal of Research in Clinical Medicine
Subjects:
cardio-embolic stroke
atrial fibrillation
warfarin
anticoagulants
neurologic manifestation
Online Access:https://jrcm.tbzmed.ac.ir/PDF/jrcm-10-6.pdf

Internet

https://jrcm.tbzmed.ac.ir/PDF/jrcm-10-6.pdf

Similar Items